Unaudited Consolidated Statements of Changes in Equity - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-in Capital	Retained Earnings (Deficit)	Accumulated Other Comprehensive Income	Non-controlling Interest
Common stock issued at the beginning of the period (shares) at Sep. 30, 2021		122,173,000
Stockholders' equity, balance at the beginning of the period at Sep. 30, 2021	$ 582,219	$ 1,223	$ (2,837)	$ 582,052	$ (11,182)	$ 11,415	$ 1,548
Treasury stock, balance at the beginning of the period (in shares) at Sep. 30, 2021			1,664,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity based compensation expense	5,203			5,203
Issuance of common stock (in shares)		199,000
Issuance of common stock, net	824	$ 2		822
Dividends paid to non-controlling interest	(100)						(100)
Net income	6,088				5,987		101
Other comprehensive income (loss)	8,359					8,359
Common stock issued at the end of the period (shares) at Dec. 31, 2021		122,372,000
Stockholders' equity, balance at the end of the period at Dec. 31, 2021	602,593	$ 1,225	$ (2,837)	588,077	(5,195)	19,774	1,549
Treasury stock, balance at the end of the period (in shares) at Dec. 31, 2021			1,664,000
Common stock issued at the beginning of the period (shares) at Sep. 30, 2021		122,173,000
Stockholders' equity, balance at the beginning of the period at Sep. 30, 2021	582,219	$ 1,223	$ (2,837)	582,052	(11,182)	11,415	1,548
Treasury stock, balance at the beginning of the period (in shares) at Sep. 30, 2021			1,664,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	13,462
Other comprehensive income (loss)	32,431
Common stock issued at the end of the period (shares) at Mar. 31, 2022		122,766,000
Stockholders' equity, balance at the end of the period at Mar. 31, 2022	638,071	$ 1,229	$ (2,837)	592,105	2,135	43,846	1,593
Treasury stock, balance at the end of the period (in shares) at Mar. 31, 2022			1,664,000
Common stock issued at the beginning of the period (shares) at Dec. 31, 2021		122,372,000
Stockholders' equity, balance at the beginning of the period at Dec. 31, 2021	602,593	$ 1,225	$ (2,837)	588,077	(5,195)	19,774	1,549
Treasury stock, balance at the beginning of the period (in shares) at Dec. 31, 2021			1,664,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity based compensation expense	5,386			5,386
Issuance of common stock (in shares)		394,000
Issuance of common stock, net	(1,354)	$ 4		(1,358)
Net income	7,374				7,330		44
Other comprehensive income (loss)	24,072					24,072
Common stock issued at the end of the period (shares) at Mar. 31, 2022		122,766,000
Stockholders' equity, balance at the end of the period at Mar. 31, 2022	$ 638,071	$ 1,229	$ (2,837)	592,105	2,135	43,846	1,593
Treasury stock, balance at the end of the period (in shares) at Mar. 31, 2022			1,664,000
Common stock issued at the beginning of the period (shares) at Sep. 30, 2022	123,411,000	123,411,000
Stockholders' equity, balance at the beginning of the period at Sep. 30, 2022	$ 710,093	$ 1,235	$ (2,837)	607,748	61,016	42,931	0
Treasury stock, balance at the beginning of the period (in shares) at Sep. 30, 2022	1,664,000		1,664,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity based compensation expense	$ 6,196			6,196
Issuance of common stock (in shares)		156,000
Issuance of common stock, net	2,412	$ 2		2,410
Net income	9,268				9,268
Other comprehensive income (loss)	1,763					1,763
Common stock issued at the end of the period (shares) at Dec. 31, 2022		123,567,000
Stockholders' equity, balance at the end of the period at Dec. 31, 2022	$ 729,732	$ 1,237	$ (2,837)	616,354	70,284	44,694	0
Treasury stock, balance at the end of the period (in shares) at Dec. 31, 2022			1,664,000
Common stock issued at the beginning of the period (shares) at Sep. 30, 2022	123,411,000	123,411,000
Stockholders' equity, balance at the beginning of the period at Sep. 30, 2022	$ 710,093	$ 1,235	$ (2,837)	607,748	61,016	42,931	0
Treasury stock, balance at the beginning of the period (in shares) at Sep. 30, 2022	1,664,000		1,664,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 19,900
Other comprehensive income (loss)	$ (3,001)
Common stock issued at the end of the period (shares) at Mar. 31, 2023	123,944,000	123,944,000
Stockholders' equity, balance at the end of the period at Mar. 31, 2023	$ 739,305	$ 1,240	$ (2,837)	620,056	80,916	39,930	0
Treasury stock, balance at the end of the period (in shares) at Mar. 31, 2023	1,664,000
Common stock issued at the beginning of the period (shares) at Dec. 31, 2022		123,567,000
Stockholders' equity, balance at the beginning of the period at Dec. 31, 2022	$ 729,732	$ 1,237	$ (2,837)	616,354	70,284	44,694	0
Treasury stock, balance at the beginning of the period (in shares) at Dec. 31, 2022			1,664,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity based compensation expense	6,004			6,004
Issuance of common stock (in shares)		377,000
Issuance of common stock, net	(2,299)	$ 3		(2,302)
Net income	10,632				10,632
Other comprehensive income (loss)	$ (4,764)					(4,764)
Common stock issued at the end of the period (shares) at Mar. 31, 2023	123,944,000	123,944,000
Stockholders' equity, balance at the end of the period at Mar. 31, 2023	$ 739,305	$ 1,240	$ (2,837)	$ 620,056	$ 80,916	$ 39,930	$ 0
Treasury stock, balance at the end of the period (in shares) at Mar. 31, 2023	1,664,000